3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 3
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Other hematologic neoplasm
1
Myeloid
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
438
Stomach Neoplasms
248
Carcinoma, Hepatocellular
245
Rectal Neoplasms
211
Colonic Neoplasms
204
Pancreatic Neoplasms
171
Esophageal Neoplasms
113
Neoplasm Metastasis
74
Liver Neoplasms
71
Neoplasms
62
Esophageal Squamous Cell Carcinoma
62
Gastrointestinal Stromal Tumors
36
Cholangiocarcinoma
36
Gastrointestinal Neoplasms
31
Parkinson Disease 4, Autosomal Dominant Lewy Body
25
Gallbladder Neoplasms
25
Adenocarcinoma Of Esophagus
24
Biliary Tract Neoplasms
23
Anus Neoplasms
22
Adenocarcinoma
21
Recurrence
19
Bile Duct Neoplasms
19
Breast Neoplasms
18
Digestive System Neoplasms
17
Lung Neoplasms
13
Uterine Cervical Neoplasms
11
Prostatic Neoplasms
11
Carcinoma
11
Digestive System Diseases
10
Peritoneal Neoplasms
9
Interventions
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pathologic Processes
×
Gastrointestinal
×
Clear all
NCT03464305
2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3
Active not recruiting
148 enrolled